patent-istock-579425600-duncan-andison

Duncan_Andison / iStockphoto.com

2 March 2017Americas

Federal Circuit affirms district court’s Bayer ruling

The US Court of Appeals for the Federal Circuit has partially affirmed a ruling by a district court in a patent dispute between Bayer and Dow Agrosciences.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Federal Circuit denies CardiAQ injunction request against Neovasc

5 September 2017 The US Court of Appeals for the Federal Circuit has affirmed a district court decision which stated that CardiAQ is not entitled to injunctive relief, despite a $91 million damages payout from Neovasc.

Federal Circuit denies further term extensions to shoulder surgery patentee

9 February 2021 The US Court of Appeals for the Federal Circuit has upheld a decision by a district court that an inventor cannot further extend his shoulder surgery patent after already being granted a term adjustment period by the US Patent and Trademark Office.

More on this story

Federal Circuit denies CardiAQ injunction request against Neovasc

5 September 2017 The US Court of Appeals for the Federal Circuit has affirmed a district court decision which stated that CardiAQ is not entitled to injunctive relief, despite a $91 million damages payout from Neovasc.

Federal Circuit denies further term extensions to shoulder surgery patentee

9 February 2021 The US Court of Appeals for the Federal Circuit has upheld a decision by a district court that an inventor cannot further extend his shoulder surgery patent after already being granted a term adjustment period by the US Patent and Trademark Office.

More on this story

Federal Circuit denies CardiAQ injunction request against Neovasc

5 September 2017 The US Court of Appeals for the Federal Circuit has affirmed a district court decision which stated that CardiAQ is not entitled to injunctive relief, despite a $91 million damages payout from Neovasc.

Federal Circuit denies further term extensions to shoulder surgery patentee

9 February 2021 The US Court of Appeals for the Federal Circuit has upheld a decision by a district court that an inventor cannot further extend his shoulder surgery patent after already being granted a term adjustment period by the US Patent and Trademark Office.

More features

Bayer gains exclusive licence for heart drug in Japan

EPO delivers key Novo Nordisk, GSK and Inhibrx rulings

McGuireWoods expands team with ex-Novo Nordisk GC

Paul, Weiss swoops for senior duo from Weil, Gotshal

UPC bans Meril Life Sciences from selling infringing heart valve

SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic

Kathi Vidal to rejoin previous firm as partner following USPTO departure

GSK triumphs in EPO appeal, revoking Pfizer patent